The FDA made several decisions regarding gene and cell therapy in 2025. There were multiple approvals in 2025, with one source noting 55 new products were approved, although the specifics of these approvals are not clear. The year's developments in gene therapy are being reviewed and summarized by various outlets, with some highlighting the top-selling gene therapies and others looking ahead to upcoming decisions in 2026.